Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300073113Phase 4Not yet recruiting
Phase 4, randomised trial of esketamine and ciprofol (4 arms), sponsored by The Affiliated Hospital of Xuzhou Medical University. Primary endpoint: Incidence of intraoperative hypotension. Planned start Nov 2022; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300073113.